Evidence map›Paper›PMID 33028687›Full record

ArticlemSphere2020

Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.

Trenton J Davis, Ava V Karanjia, Charity N Bhebhe, Sarah B West, Matthew Richardson, Heather D Bean

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Calcium regulation ofApplied and environmental microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in immunology · 2025
    Review
  11. Review
  12. Review
  13. A Pilot Study forSensors (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Pseudomonas aeruginosa in the Cystic Fibrosis Lung.Advances in experimental medicine and biology · 2022
    Article
  17. What Makes Pseudomonas aeruginosa a Pathogen?Advances in experimental medicine and biology · 2022
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Trenton J DavisSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-3167-0299
Ava V KaranjiaSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0001-6888-7005
Charity N BhebheSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Sarah B WestSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Matthew RichardsonDepartment of Respiratory Sciences, College of Life Sciences, University of Leicester, Leicester, UK.
Heather D BeanSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA Heather.D.Bean@asu.edu.ORCID 0000-0001-8821-0659
Arizona State University · USUniversity of Leicester · GB

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss · 2010 to 2026
$21.4M
Improving outcomes in CF patients: Toward rapid detection of P. aeruginosaR56HL139846 · NHLBI · DARTMOUTH COLLEGE · PI HILL, JANE · 2018 to 2018
$514k
NHLBI NIH HHS R56 HL139846NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptation, PhysiologicalBiomarkersChromatography, GasChronic DiseaseCystic FibrosisHumansLungMass SpectrometryMetabolomePhenotypePseudomonas aeruginosaPseudomonas InfectionsQuality of LifeRespiratory Tract InfectionsVolatile Organic CompoundsVolatilizationBiomarkersVolatile Organic Compoundsadaptationbiomarkerschronic infectioncystic fibrosismetabolomicsPseudomonas aeruginosavolatile organic compounds

Identifiers

PMID33028687
PMCPMC7568651
OpenAlexW3091814494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.